Annual CFF
$186.24 M
-$11.08 M-5.61%
December 31, 2023
Summary
- As of February 7, 2025, WGS annual cash flow from financing activities is $186.24 million, with the most recent change of -$11.08 million (-5.61%) on December 31, 2023.
- During the last 3 years, WGS annual CFF has risen by +$57.18 million (+44.31%).
- WGS annual CFF is now -62.28% below its all-time high of $493.73 million, reached on December 31, 2021.
Performance
WGS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$13.97 M
+$14.36 M+3672.38%
September 30, 2024
Summary
- As of February 7, 2025, WGS quarterly cash flow from financing activities is $13.97 million, with the most recent change of +$14.36 million (+3672.38%) on September 30, 2024.
- Over the past year, WGS quarterly CFF has increased by +$14.36 million (+3672.38%).
- WGS quarterly CFF is now -97.20% below its all-time high of $499.40 million, reached on September 1, 2021.
Performance
WGS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$60.24 M
+$14.88 M+32.80%
September 30, 2024
Summary
- As of February 7, 2025, WGS TTM cash flow from financing activities is $60.24 million, with the most recent change of +$14.88 million (+32.80%) on September 30, 2024.
- Over the past year, WGS TTM CFF has increased by +$14.88 million (+32.80%).
- WGS TTM CFF is now -91.35% below its all-time high of $696.27 million, reached on June 1, 2022.
Performance
WGS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
WGS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5.6% | +3672.4% | +32.8% |
| 3 y3 years | +44.3% | -89.5% | -81.8% |
| 5 y5 years | +25.8% | -89.5% | -81.8% |
WGS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -62.3% | at low | -93.0% | +1457.4% | -91.3% | +32.8% |
| 5 y | 5-year | -62.3% | +44.3% | -97.2% | +689.6% | -91.3% | +1396.4% |
| alltime | all time | -62.3% | +44.3% | -97.2% | +689.6% | -91.3% | +1396.4% |
GeneDx Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.97 M(-3672.4%) | $60.24 M(+32.8%) |
| Jun 2024 | - | -$391.00 K(-10.7%) | $45.36 M(-14.6%) |
| Mar 2024 | - | -$438.00 K(-100.9%) | $53.14 M(-71.5%) |
| Dec 2023 | $186.24 M(-5.6%) | $47.10 M(-5270.5%) | $186.24 M(+33.8%) |
| Sep 2023 | - | -$911.00 K(-112.3%) | $139.20 M(-0.2%) |
| Jun 2023 | - | $7.39 M(-94.4%) | $139.46 M(-57.8%) |
| Mar 2023 | - | $132.66 M(>+9900.0%) | $330.13 M(+67.3%) |
| Dec 2022 | $197.31 M | $65.00 K(-110.0%) | $197.31 M(+0.6%) |
| Sep 2022 | - | -$647.00 K(-100.3%) | $196.22 M(-71.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $198.06 M(<-9900.0%) | $696.27 M(+40.4%) |
| Mar 2022 | - | -$160.00 K(-84.5%) | $495.85 M(+0.4%) |
| Dec 2021 | $493.73 M(+282.6%) | - | - |
| Dec 2021 | - | -$1.03 M(-100.2%) | $493.73 M(-0.2%) |
| Sep 2021 | - | $499.40 M(<-9900.0%) | $494.76 M(<-9900.0%) |
| Jun 2021 | - | -$2.37 M(+4.0%) | -$4.65 M(+104.0%) |
| Mar 2021 | - | -$2.28 M | -$2.28 M |
| Dec 2020 | $129.06 M(-12.8%) | - | - |
| Dec 2019 | $148.01 M | - | - |
FAQ
- What is GeneDx Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for GeneDx Holdings?
- What is GeneDx Holdings annual CFF year-on-year change?
- What is GeneDx Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for GeneDx Holdings?
- What is GeneDx Holdings quarterly CFF year-on-year change?
- What is GeneDx Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for GeneDx Holdings?
- What is GeneDx Holdings TTM CFF year-on-year change?
What is GeneDx Holdings annual cash flow from financing activities?
The current annual CFF of WGS is $186.24 M
What is the all time high annual CFF for GeneDx Holdings?
GeneDx Holdings all-time high annual cash flow from financing activities is $493.73 M
What is GeneDx Holdings annual CFF year-on-year change?
Over the past year, WGS annual cash flow from financing activities has changed by -$11.08 M (-5.61%)
What is GeneDx Holdings quarterly cash flow from financing activities?
The current quarterly CFF of WGS is $13.97 M
What is the all time high quarterly CFF for GeneDx Holdings?
GeneDx Holdings all-time high quarterly cash flow from financing activities is $499.40 M
What is GeneDx Holdings quarterly CFF year-on-year change?
Over the past year, WGS quarterly cash flow from financing activities has changed by +$14.36 M (+3672.38%)
What is GeneDx Holdings TTM cash flow from financing activities?
The current TTM CFF of WGS is $60.24 M
What is the all time high TTM CFF for GeneDx Holdings?
GeneDx Holdings all-time high TTM cash flow from financing activities is $696.27 M
What is GeneDx Holdings TTM CFF year-on-year change?
Over the past year, WGS TTM cash flow from financing activities has changed by +$14.88 M (+32.80%)